EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Oncogenic function and transcriptional dynamics of MYCN in liver tumorigenesis

Xian-Yang Qin iD, Yali Xu, Hricha Mishra, Yohei Shirakami iD, Shiou-Hwei Yeh, Chiao-Ling Li iD, Kazushi Numata iD, Yusuke Suenaga, Feifei Wei iD, Reiko Ando iD, Hajime Nishimura, Erina Furuhata iD und 14 weitere

Proceedings of the National Academy of Sciences · 2026

DOI: 10.1073/pnas.2521923123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Xian-Yang Qin und 25 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Cellular Function Conversion Technology, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa 230-0045, Japan. Hauptthemen laut MEDLINE: N-Myc Proto-Oncogene Protein, Liver Neoplasms, Carcinoma, Hepatocellular, Carcinogenesis. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development (AMED), MEXT | JSPS | Japan Society for the Promotion of Science London (JSPS), MEXT | Japan Science and Technology Agency (JST).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality. It is often diagnosed at advanced stages and characterized by high recurrence rates. Although chronic liver inflammation and metabolic dysfunction are established contributors to tumorigenesis, the molecular mechanisms that link microenvironmental stress to malignant transformation remain poorly understood. MYCN, a proto-oncogenic transcription factor, has emerged as a potential biomarker of cancer stemness. However, its role in hepatocarcinogenesis remains unclear. In this study, we elucidated the oncogenic role of MYCN and its dynamic transcriptional regulation during liver tumorigenesis. Using a hydrodynamic tail vein injection-based transposon system in mice, we demonstrated that MYCN overexpression synergizes with AKT activation to promote liver tumorigenesis. Transcriptomic profiling revealed that MYCN-driven tumors exhibited features of human HCC subtypes enriched in stress-adaptive transcriptional programs. Time-resolved spatial transcriptomics further uncovered a MYCN-enriched niche characterized by epithelial–mesenchymal transition (EMT) and Wnt/β-catenin signaling, which expanded during tumor progression and was spatially proximate to transformed malignant cells. To translate these findings to human HCC, we developed a machine learning-based MYCN niche score and validated its clinical relevance across multiple human HCC cohorts. This score reliably predicted recurrence risk and identified EMT-prone microenvironments, with stronger predictive performance in nontumor tissues, suggesting its potential in detecting precancerous niches predisposed to de novo tumorigenesis. Collectively, our findings establish MYCN as a functional driver and spatial marker of tumor-promoting microenvironments in liver tumorigenesis; additionally, we propose a clinically actionable strategy to identify high-risk patients through transcriptomic profiling of nontumor liver tissue.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

N-Myc Proto-Oncogene ProteinLiver NeoplasmsCarcinoma, HepatocellularCarcinogenesisAnimalsHumansMiceGene Expression Regulation, NeoplasticEpithelial-Mesenchymal TransitionWnt Signaling PathwayCell Transformation, NeoplasticLiverTranscription, Genetic

Stichwörter der Autor:innen

MYCNliver canceroncogenespatial transcriptometumor microenvironment

Substanzen

N-Myc Proto-Oncogene ProteinMYCN protein, humanMYCN protein, mouse

Autor:innen und Institutionen

  • Laboratory for Cellular Function Conversion Technology, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa 230-0045, Japan.
  • Department of Gastroenterology, Graduate School of Medicine, Gifu University, Gifu 501-1194, Japan.
  • Department of Microbiology, National Taiwan University College of Medicine, Taipei 100, Taiwan.
  • Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Kanagawa 232-0024, Japan.
  • Laboratory of Evolutionary Oncology, Chiba Cancer Center Research Institute, Chiba 260-8717, Japan.
  • Division of Cancer Immunotherapy, Kanagawa Cancer Center Research Institute, Yokohama, Kanagawa 241-8515, Japan.

ORCID-Profile: Xian-Yang Qin, Yohei Shirakami, Chiao-Ling Li, Kazushi Numata, Feifei Wei, Reiko Ando, Erina Furuhata, Yutaka Furutani, Masahiro Yamamoto, Masanori Goto, Hiroyuki Tomita, Luc Gailhouste, Masahito Shimizu, Yoshitaka Hippo, Harukazu Suzuki

Förderung

  • Japan Agency for Medical Research and Development (AMED)
  • MEXT | JSPS | Japan Society for the Promotion of Science London (JSPS)
  • MEXT | Japan Science and Technology Agency (JST)

Zitieren

APA

Qin, X. Y., Xu, Y., Mishra, H., Shirakami, Y., Yeh, S. H., Li, C. L., Numata, K., Suenaga, Y., Wei, F., Ando, R., Nishimura, H., Furuhata, E., Maeda, S., Furutani, Y., Yanaka, K., Yamamoto, M., Goto, M., Takasawa, A., Nishikawa, Y., …, & Suzuki, H. (2026). Oncogenic function and transcriptional dynamics of MYCN in liver tumorigenesis. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2521923123

Vancouver

Qin XY, Xu Y, Mishra H, Shirakami Y, Yeh SH, Li CL, et al. Oncogenic function and transcriptional dynamics of MYCN in liver tumorigenesis. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2521923123

BibTeX
@article{Qin2026,
  author = {Qin, Xian-Yang and Xu, Yali and Mishra, Hricha and Shirakami, Yohei and Yeh, Shiou-Hwei and Li, Chiao-Ling and Numata, Kazushi and Suenaga, Yusuke and Wei, Feifei and Ando, Reiko and Nishimura, Hajime and Furuhata, Erina and Maeda, Shiori and Furutani, Yutaka and Yanaka, Kaori and Yamamoto, Masahiro and Goto, Masanori and Takasawa, Akira and Nishikawa, Yuji and Tomita, Hiroyuki and Gailhouste, Luc and Matsuura, Tomokazu and Chen, Pei-Jer and Shimizu, Masahito and Hippo, Yoshitaka and Suzuki, Harukazu},
  title = {Oncogenic function and transcriptional dynamics of MYCN in liver tumorigenesis},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  doi = {10.1073/pnas.2521923123}
}
Kostenlos starten →